Allene Diaz Net Worth

The estimated Net Worth of Allene M. Diaz is at least $28.4 Thousand dollars as of 15 July 2024. Ms. Diaz owns over 4,677 units of Allena Pharmaceuticals Inc stock worth over $1,388 and over the last 6 years she sold ALNA stock worth over $26,970. In addition, she makes $0 as Independent Director at Allena Pharmaceuticals Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Diaz ALNA stock SEC Form 4 insiders trading

Allene has made over 4 trades of the Allena Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 4,677 units of ALNA stock worth $374 on 15 July 2024.

The largest trade she's ever made was exercising 8,000 units of Allena Pharmaceuticals Inc stock on 15 July 2022 worth over $640. On average, Allene trades about 1,098 units every 43 days since 2019. As of 15 July 2024 she still owns at least 17,353 units of Allena Pharmaceuticals Inc stock.

You can see the complete history of Ms. Diaz stock trades at the bottom of the page.

Allene Diaz biography

Allene M. Diaz serves as Independent Director of the Company. She currently leads AMD Consulting, a New Product and Portfolio Management consulting practice. She served as the Senior Vice President, R&D Portfolio Management at GlaxoSmithKline until June 2020. Prior to that, she served as the Senior Vice President of Global Commercial Development and Program Strategy at TESARO, Inc. since May 2015. Prior to her tenure at TESARO, Inc., Ms. Diaz spent seven years at EMD/Merck Serono, divisions of Merck KGaA, Darmstadt, Germany in a variety of roles, including Senior Vice President, Managed Markets, including Senior Vice President, Managed Markets and Senior Vice President, Head of US Oncology Commercial. She also spent time as the Head of Global Strategic Planning and as the Head of the Global Oncology Business Unit for Merck Serono. In addition, Ms. Diaz has held management positions at several leading biopharmaceutical companies, including Amylin Pharmaceuticals, Biogen and Pfizer. Ms. Diaz also served as an independent director of Erytech Pharma SA, a clinical-stage biopharmaceutical company developing innovative therapies for cancer, from September 2016 to September 2019. Ms. Diaz has a B.S. from Florida State University.

How old is Allene Diaz?

Allene Diaz is 56, she's been the Independent Director of Allena Pharmaceuticals Inc since 2019. There are 7 older and 5 younger executives at Allena Pharmaceuticals Inc. The oldest executive at Allena Pharmaceuticals Inc is Dr. Alexey L. Margolin, 68, who is the Co-Founder & Chairman.

What's Allene Diaz's mailing address?

Allene's mailing address filed with the SEC is 2855 GAZELLE COURT, , CARLSBAD, CA, 92010.

Insiders trading at Allena Pharmaceuticals Inc

Over the last 7 years, insiders at Allena Pharmaceuticals Inc have traded over $0 worth of Allena Pharmaceuticals Inc stock and bought 1,537,428 units worth $21,523,992 . The most active insiders traders include Andrew A. F. Hack, James N Topper, and Harbor Master Investors (Ca.... On average, Allena Pharmaceuticals Inc executives and independent directors trade stock every 134 days with the average trade being worth of $15,887. The most recent stock trade was executed by Louis Md Brenner on 15 November 2021, trading 125,582 units of ALNA stock currently worth $10,047.

What does Allena Pharmaceuticals Inc do?

Complete history of Ms. Diaz stock trades at Ionis Pharmaceuticals Inc, Mersana Therapeutics Inc, and Allena Pharmaceuticals Inc

Allena Pharmaceuticals Inc executives and stock owners

Allena Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Louis Brenner,
  President, Chief Executive Officer, Director
• Edward Wholihan,
  Chief Financial Officer
• Dr. Louis Brenner,
  Pres, CEO & Director
• Dr. Alexey L. Margolin,
  Co-Founder & Chairman
• Alexey Margolin,
  Chairman of the Board, Co-Founder
• Geoffrey Swire,
  Acting Chief Operating Officer, Interim Principal Operating Officer, Senior Vice President - Corporate Development
• James Topper,
  Independent Director
• Gino Santini,
  Independent Director
• Andrew Hack,
  Independent Director
• Allene Diaz,
  Independent Director
• Robert Alexander,
  Independent Director
• Ann Miller,
  Director
• Stephen Yu,
  Sr. VP of Corp. Quality
• Dr. David J. Clark,
  Chief Medical Officer
• Alicja Januszewicz Ph.D.,
  VP of People & Culture
• Hugh Wight,
  Sr. VP of Technical Operations
• Dr. Richard D. Katz,
  CFO, Principal Financial Officer & Principal Accounting Officer
• Robert Gallotto,
  Co-Founder & Strategic Adviser
• Bio Capital Ii Lp Hbm,
  10% owner
• Robert I Tepper,
  Director
• Vi, L.L.C.Fhm Vi, L.P.Frazi...,
  
• Harbor Master Investors (Ca...,
  10% owner
• Venture Partners Vii L.P.De...,
  
• Stephen Kraus,
  Director
• Rock Ventures Ii, L.P.Third...,
  
• Axel Bolte,
  Director
• Richard D Katz,
  Chief Financial Officer
• Mark J. Fitzpatrick,
  Director